Dr Kafeel Khan who saved hundreds of infants sacked amid Yogi’s visit

Mangaluru, May 22: An elderly cardiac patient from Dakshina Kannada, who was stranded in Saudi Arabia due to covid-19 lock-down, has finally reached his homeland thanks to the timely intervention by Humanity Forum Jubail and Indian Social Forum.

The elderly man hailing from Kadaba area of Dakshina Kannada was admitted to a hospital in Madinah. However, his condition continued to worsen due to lack of proper treatment. The efforts by his family members to bring him back home had not yielded results.

Meanwhile, one of the relatives of the patient, Ansari Suratkal, who happens to be a DKSC activist, brought the issue to the notice of the Karnataka unit of the Indian Social Forum in Dammam. ISF contacted Humanity Forum president Zakariya Jokatte, who helped the patient to speak directly union minister D V Sadananda Gowda in a video conference organised by coastaldigest.com.

Humanity Forum also persuaded the Indian Embassy to allow the stranded cardiac patient to fly back to India through Dammam-Bengaluru repatriation flight on May 20. 

However, it was not easy for the patient to travel from Madinah to Dammam International Airport due to lock-down and curfew. ISF not only obtained travel permission for him but also arranged vehicle. Jeddah and Riyadh units of ISF helped in obtaining permission letter in their respective places in spite of travel ban imposed by the police. Madinah unit of ISF arranged vehicle for transportation. Zakariya Jokatte bore the air ticket and other expenses of the patient.

Mangaluru, May 4: An engineering student has claimed to have received 600 threat calls in the past few days from unidentified people for starting fish business during the lockdown in Kavoor. 

According to Sakshath Shetty, resident of Kavoor, he started receiving threat calls from various people after he started selling fish during the lockdown. 

Police said they have been able to identify some of the numbers from where the threat calls were made and investigation is under way.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.